TELA Bio Inc. (TELA)
NASDAQ: TELA
· Real-Time Price · USD
1.58
-0.02 (-1.25%)
At close: Aug 15, 2025, 3:59 PM
1.58
-0.05%
After-hours: Aug 15, 2025, 04:04 PM EDT
TELA Bio Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -9.92M | -11.26M | -9.21M | -10.37M | -12.6M | -5.66M | -12.89M | -10.96M | -10.79M | -12.03M | -9.98M | -10.71M | -12.74M | -10.86M | -8.62M | -8.27M | -8.26M | -8.14M |
Depreciation & Amortization | 270K | 267K | 266K | 263K | 249K | 234K | 161K | 218K | 214K | 215K | 207K | 205K | 621K | 154K | 137K | 127K | 131K | 140K |
Stock-Based Compensation | 985K | 1.04M | 1.09M | 1.08M | 1.09M | 1.1M | 1.24M | 1.37M | 1.29M | 1.13M | 1.04M | 1.03M | 1.02M | 901K | 822K | 733K | 1.41M | 694K |
Other Working Capital | 684K | -684K | -1.14M | 2.04M | 629K | -3.02M | 2.23M | 1.89M | 1.3M | -1.29M | 1.49M | 985K | 2.56M | -1.42M | -60K | 1.36M | 1.23M | -844K |
Other Non-Cash Items | 151K | 755K | 1.25M | 824K | 474K | -6.89M | 4.45M | 428K | 265K | 619K | -146K | 1.11M | 2.05M | 1.12M | 281K | 822K | 262K | 738K |
Deferred Income Tax | 33K | 52K | n/a | n/a | n/a | n/a | -3.9M | 163K | -255K | n/a | n/a | n/a | n/a | n/a | -10K | 41K | n/a | -17K |
Change in Working Capital | 579K | -579K | -926K | -779K | 90K | -3.17M | -109K | 1.81M | -1.99M | -1.51M | -2.1M | 718K | -2.64M | -1.74M | -2.2M | -87K | 821K | -2M |
Operating Cash Flow | -7.91M | -9.72M | -7.53M | -8.98M | -10.7M | -14.38M | -11.05M | -6.97M | -11.26M | -11.57M | -10.98M | -7.65M | -11.69M | -10.43M | -9.59M | -6.63M | -5.63M | -8.59M |
Capital Expenditures | -114K | -32K | -264K | -122K | -299K | -304K | -205K | -134K | -157K | -115K | -1.05M | -290K | -200K | -336K | -289K | -291K | -25K | -22K |
Cash Acquisitions | n/a | n/a | n/a | -5.37M | 366K | 5M | 12K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 318K | 170K | 74K | 5.37M | n/a | n/a | n/a | n/a | n/a | n/a | 1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 204K | 138K | -190K | -122K | 67K | 4.7M | -193K | -134K | -157K | -115K | -1.05M | -290K | -200K | -336K | -289K | -291K | -25K | -22K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 60K | n/a | -11K | -19K | -11K | 164K | n/a | n/a | -1K | -279K | -219K | n/a | n/a | -153K | 38K | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -3K | -177K | -11K | -19K | -11K | -328K | -4K | 76K | 46.41M | -235K | 56K | -106K | 6.65M | -146K | 174K | 259K | 116K | 36K |
Financial Cash Flow | -3K | -116K | 42.91M | 98K | -5K | 56K | 22K | 71K | 46.41M | -235K | -219K | 34.57M | 6.65M | -146K | 174K | 259K | 116K | 36K |
Net Cash Flow | -7.86M | -9.84M | 35.37M | -9.2M | -10.65M | -9.59M | -11.21M | -7.06M | 35.14M | -11.89M | -12.21M | 26.5M | -5.29M | -10.91M | -9.71M | -6.66M | -5.54M | -8.56M |
Free Cash Flow | -8.02M | -9.76M | -7.79M | -9.11M | -11M | -14.69M | -11.26M | -7.1M | -11.42M | -11.69M | -12.03M | -7.94M | -11.89M | -10.77M | -9.88M | -6.92M | -5.65M | -8.61M |